Cargando…
Genetic Screening for the Risk of Type 2 Diabetes: Worthless or valuable?
Autores principales: | Lyssenko, Valeriya, Laakso, Markku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920800/ https://www.ncbi.nlm.nih.gov/pubmed/23882036 http://dx.doi.org/10.2337/dcS13-2009 |
Ejemplares similares
-
Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
por: Raz, Itamar
Publicado: (2013) -
Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
por: DeFronzo, Ralph A., et al.
Publicado: (2013) -
Role of Reduced β-Cell Mass Versus Impaired β-Cell Function in the Pathogenesis of Type 2 Diabetes
por: Meier, Juris J., et al.
Publicado: (2013) -
Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes
por: Stefan, Norbert, et al.
Publicado: (2008) -
Type 1 Diabetes Is Associated With Enterovirus Infection in Gut Mucosa
por: Oikarinen, Maarit, et al.
Publicado: (2012)